CD44v6 is a splice variant of CD44, whose overexpression in many cancers, including pancreatic cancer, colon cancer and breast cancer, has been shown to confer an increased migratory and invasive capacity (Table S1). This evidence concerns the gene CD44 and familial pancreatic carcinoma.